´
V. Pejchal, A. Imramovsky
2244
The reaction mixture was heated to 50 ꢁC and hydrogen was introduced under the
surface of the mixture (the pressure of hydrogen was constant at 1.5 MPa during the
operation). The temperature of reaction mixture was maintained between 60 and
80 ꢁC. When hydrogen consumption was constant for more than hour, reduction
was terminated. The reaction mixture was filtered through a pressure filter to
remove the catalyst and the isolated catalyst was washed with DMAC (50 mL,
55 ꢁC). DMAC (280 g) was removed from the filtrates under reduced pressure
(26 mBar). The content of the autoclave was cooled to 30 ꢁC and distilled water
(200 mL) was slowly added. The reaction mixture was stirred for another 1 h.
Precipitated product II was isolated by filtration, washed with water (100 mL), and
dried in oven (80 ꢁC) to constant weight, to give 42.3 g of desired 4-amino-N-
(4-carbamoylphenyl)benzamide II with purity higher than 98 % (HPLC).
1
White solid, yield 94.4 %. H NMR (500,13 MHz, DMSO-d6) : d 10.06 (1H, s,
NH–CO); 8.00 (1H, s, NH2–CO); 7.84 (4H, m, H4, H5); 7.75 (2H, d, J = 8,6 Hz,
H3); 7.26 (1H, s, NH2–CO); 6.66 (2H, d, J = 8,6 Hz, H2); 5.80 (2H, s, NH2). 13C
NMR (125,77 MHz, DMSO-d6): d 168.5; 166.3; 152.8; 142.9; 130.1; 130.0; 128.6;
121.1; 119.8; 113.2.
Acknowledgments This study was supported by the institutional support of The Ministry of Education,
Youth, and Sports of the Czech Republic and by the University of Pardubice, Faculty of chemical
Technology.
References
1. W. Herbst, K. Hunger, Industrial organic pigments (Wiley-VCH GmbH, Weinheim, 2004), p. 358
¨
¨
2. M. Rodel, F. Thieme, H. Buchholz, B. Konig, Synth. Commun. 32, 1181 (2002)
3. J. Sheela, K. Navita, K. Deepak, T. Prapti, Acta Pharmaceutica 52, 197 (2002)
4. Ho, K.K., Roughton, A.L., Neagu, I., Chan, J.H., Ansari, N., Morris, M.L., Rong, Y., Ohlmeyer, M.,
Cooke, A.J., Edwards, A.S., Bennet, D.J. N-benzyl, N’-arylcarbonylpiperazine derivates as LXR
modulators. WO 2009/024550 A1, Issued country US, 26 Feb 2009
5. H. Ogawa, H. Yamashita, K. Kondo, Y. Yamamura, H.J. Miyamoto, Med. Chem. 39, 3547 (1996)
6. Aoki, T., Takahashi, A., Sato, I., Manome, Y., Yamaguchi, T., Yamada, S., Ishigami, S., Nishimata,
T., Gengyou, K., Shimanuki, E., Sato, H., Narita, S., Kogi, K. Substituted cyclic amine compound,
production process thereof and pharmaceutical composition for circulatory organ use containing the
same. US US5728835 A1, Issued country US, 17 March 1998
7. Baker, W.R., Stasiak, M., Macleod, D. Substituted acetanilides and benzamides for the treatment of
asthma and pulmonary inflamation. WO 2005/025498 A2, Issued country US, 24 March 2005
8. J. DeRuiter, R.A. Davis, V.G. Wandrekar, C.A. Mayfield, J. Med. Chem. 34, 2120 (1991)
9. Exelixis, Inc.: C-Met Modulators and methods of use. WO 2005/30140 A2, Issued country US, 24
Sept 2004
10. R.W. Hartmann, M. Reichert, S. Goehring, Eur. J. Med. Chem. 29, 807 (1994)
11. D. Laliberte, T. Maris, J.D. Wuest, Can. J. Org. Chem. 82, 386 (2004)
12. L. Hu, X. Cao, L. Shi, G.Z. Fenqiang, J. Lu, H. Gu, Org. Lett. 13, 5640 (2011)
13. J.P. Collman, K.M. Kosydar, M. Bressan, W. Lamanna, T.J. Garrett, Am. Chem. Soc. 106, 2569
(1984)
14. Y. Mikami, A. Noujima, T. Mitsudome, T. Mizugaki, K. Jitsukawa, K. Kaneda, Chem. Lett. 39, 223
(2010)
123